Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873439 · ClinicalTrials.gov registry record · Early Phase 1
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC
A Early Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT05873439 is a Early Phase 1 study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 3 participants.
The verdict
NCT05873439, a Early Phase 1 study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the feasibility of genomically guided radiation therapy (RT) with concurrent chemotherapy in the management of stage II and III non-small cell lung cancer (NSCLC).
Interventions
- RADIATION Genomically Guided Radiation Therapy (RT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-05-25 |
| Est. Completion | 2024-08-21 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05873439
The ClinicalTrials.gov registry entry for NCT05873439 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genomically Guided Radiation Therapy (RT) is the first listed.
NCT05873439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05873439 about?
NCT05873439 is a clinical study titled "Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC". The purpose of the study is to determine the feasibility of genomically guided radiation therapy (RT) with concurrent chemotherapy in the management of stage II and III non-small cell lung cancer (NSCLC).
What is the current status of trial NCT05873439?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2023-05-25. Estimated completion is 2024-08-21.
What interventions are being tested in trial NCT05873439?
The interventions under investigation include: Genomically Guided Radiation Therapy (RT) (RADIATION).
Who is sponsoring clinical trial NCT05873439?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.